Medtronic plc, headquartered in Dublin, is a listed company in the field of medical technology. The company is known for its pacemakers, implantable cardioverter defibrillators, heart valves, insulin pumps, aortic stent grafts, coronary stents and neurostimulators. Medtronic manufactures more than half of all pacemakers implanted worldwide.
Market capitalization of Medtronic (MDT)
Market cap: HK$897.35 Billion
As of July 2025 Medtronic has a market cap of HK$897.35 Billion. This makes Medtronic the world's 163th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Medtronic from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | HK$897.35 B | 11.64% |
| 2024 | HK$803.77 B | -6.05% |
| 2023 | HK$855.48 B | 5.91% |
| 2022 | HK$807.74 B | -25.53% |
| 2021 | HK$1.084 T | -11.27% |
| 2020 | HK$1.222 T | 3.21% |
| 2019 | HK$1.184 T | 23.8% |
| 2018 | HK$956.64 B | 12.03% |
| 2017 | HK$853.91 B | 12.59% |
| 2016 | HK$758.41 B | -9.53% |
| 2015 | HK$838.32 B | 52.08% |
| 2014 | HK$551.23 B | 24.07% |
| 2013 | HK$444.28 B | 38.16% |
| 2012 | HK$321.56 B | 2.56% |
| 2011 | HK$313.52 B | 1.19% |
| 2010 | HK$309.85 B | -17.75% |
| 2009 | HK$376.69 B | 38.74% |
| 2008 | HK$271.50 B | -38.74% |
| 2007 | HK$443.16 B | -7.49% |
| 2006 | HK$479.07 B | -11.27% |
| 2005 | HK$539.91 B | 15.72% |
| 2004 | HK$466.56 B | 2.16% |
| 2003 | HK$456.68 B | 5.25% |
| 2002 | HK$433.88 B | -10.25% |
| 2001 | HK$483.42 B | -14.55% |
| 2000 | HK$565.75 B | 67.33% |
| 1999 | HK$338.10 B | 20.05% |
| 1998 | HK$281.63 B | 47.7% |
| 1997 | HK$190.67 B | 51.04% |
| 1996 | HK$126.24 B |
End of Day market cap according to different sources
On Jul 14th, 2025 the market cap of Medtronic was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | HK$1.201 T | 33.92% | 🇺🇸 USA |
 Stryker Corporation SYK | HK$1.171 T | 30.58% | 🇺🇸 USA |
 Edwards Lifesciences EW | HK$353.69 B | -60.59% | 🇺🇸 USA |
 Johnson & Johnson JNJ | HK$2.930 T | 226.60% | 🇺🇸 USA |
 Abbott Laboratories ABT | HK$1.795 T | 100.13% | 🇺🇸 USA |
 CONMED CNMD | HK$11.85 B | -98.68% | 🇺🇸 USA |
 Baxter BAX | HK$113.80 B | -87.32% | 🇺🇸 USA |
 Owens & Minor
OMI | HK$4.67 B | -99.48% | 🇺🇸 USA |
 Integra LifeSciences IART | HK$7.16 B | -99.20% | 🇺🇸 USA |